/
Markets
Crypto
News
Forecasts
Forex Brokers
Calendars
Macro Data
Commodity Prices
Currency Rates
Cryptocurrency Prices
Global Market Indices
Stock Prices
ETF Prices
Cryptocurrency Prices
Crypto Exchanges
Crypto Wallets
Cryptocurrency News
Cryptocurrency Forecasts
Commodity News
Forex News
Crypto News
Stock Market News
Economic News
Opinions
Broker News
Commodities
Forex
Crypto
Indices
Natural Gas Forecasts
Gold Forecasts
WTI Crude Oil Forecasts
S&P 500 Forecasts
Forex Brokers Reviews
Best Brokers Guides
Compare Forex Brokers
Best Forex Brokers
Best Forex Platforms
Best MT4 Brokers
Best for Trading Gold
Best Brokers in Australia
Best Brokers for Beginners
Best Brokers in UK
Brokers Promotions
Stock Brokers
Economic Calendar
Earnings Calendar
Splits Calendar
Dividends Calendar
Holiday Calendar
IPO Calendar
Stock Screener
Currency Converter
Global Macro indicators
Sovereign Credit Ratings
Global Major Indicators
Interest Rates
United States Indicators
China Indicators
Australia Indicators
Euro Area Indicators
EUR/USD
+0.20%
Natural Gas
-0.92%
Gold
-0.13%
BTC
+0.46%
ETH
+0.15%
SPX
+1.46%
VIX
-2.71%
Economic Calendar
EUR/USD
+0.20%
Natural Gas
-0.92%
Gold
-0.13%
BTC
+0.46%
ETH
+0.15%
SPX
+1.46%
VIX
-2.71%
Economic Calendar
BTC
+0.46%
ETH
+0.15%
XRP
+0.66%
ADA
+2.44%
SOL
-1.17%
Review
Review
Review
Exclusive-Indonesia to send general to Myanmar to highlight transition, president says
19 minutes ago
Ukrainian authorities raid billionaire Kolomoiskiy’s home – media reports
19 minutes ago
As ice recedes, Italian ship makes record journey into Antarctic
19 minutes ago
Factbox-What ending the U.S. COVID health emergency means for your pocket
20 minutes ago
India ramps up spending, cuts deficit in $550 billion budget ahead of 2024 vote
20 minutes ago
Hong Kong GDP shrinks for 4th straight quarter, but poised for recovery
20 minutes ago
USD/JPY Fundamental Daily Forecast – Traders Bracing For Hawkish Tone from Fed Chair Powell
about 1 hour ago
AUD/USD and NZD/USD Fundamental Daily Forecast – Underpinned by Dovish Fed Expectations
about 2 hours ago
ETH Fails to Make a Move ahead of Testnet Launch with Powell in Focus
about 3 hours ago
DOGE Return to $0.100 Hinged on the Fed Despite Musk Support
about 3 hours ago
ADA Price Prediction: Bulls to Target a Pre-Fed $0.418 on Djed Launch
about 4 hours ago
XRP and a Return to $0.4250 in the Hands of Fed Chair Powell
about 5 hours ago
Quick Links
:
Forecasts
Economic Calendar
Crypto
Commodities
FXTM Academy
Trade Now
ad
ad
Advertisement
Advertisement
home
stocks
AMGN
profile
AMGEN Inc.
Follow
AMGN
(
Nasdaq - US
)
Closed
252.46
+0.87 (+0.35%)
in
:
usd
•
As of: Jan 31, 2023 15:59
UTC -5
After Market
:
251
-1.46 (-0.58%)
Open
253.02
High
253.89
Low
249.95
Overview
News & Analysis
Profile
Financials
Advanced Chart
History
Earnings
Dividends
About
AMGEN Inc.
CEO
Robert A. Bradway
Headquarters
one amgen center drive
thousand oaks, ca 91320, united states
Auditor
Ernst & Young LLP
Employees
24,200
Share Holders
5,069
Website
www.amgen.com
Industry
biotechnology
Sector
health technology
Company Overview
Amgen Inc. is the leading biotech companies world wide, with a strong presence in the oncology/hematology, cardiovascular disease, neuroscience, inflammation, bone health & nephrology and neuroscience markets. It developed two most successful drugs, Epogen & Neupogen. Amgen successfully launched two next-generation products, Aranesp & Neulasta and also a biosimilar drug, Prolia/Xgeva. The acquisition of Immunex Corp gave Amgen access to the multi-blockbuster drug, Enbrel. Other products are Repatha, Blincyto, Parsabiv, Evenity, Aimovig, Lumakras/Lumykras, Kanjinti, Mvasi & Amgevita biosimilars. Amgen also has a promising pipeline of cancer drugs. It has one of the strongest cash positions in the biotech sector, which could be used to acquire more pipeline assets that could fuel long-term growth. The erythropoiesis-stimulating agents and granulocyte colony-stimulating factor franchise comprise Epogen/Aranesp and Neupogen/Neulasta respectively. Biosimilar drugs are also a key part of Amgen's growth strategy.
AMGEN Inc.
Statistics
Valuation Measures
Market Capitalization
2
134.71B
Enterprise Value
163.91B
Enterprise Value/EBITDA
(ttm)
12.61
Price to Earnings Ratio
(ttm)
14.12
Price to Book
(mrq)
37.14
Price to Sales
(ttm)
5.14
Price to Cash
(ytd)
10.73
Profitability
Gross Margin
(ttm)
75.78%
Operating Margin
(ttm)
37.33%
Profit Margin
(ttm)
25.90%
Return on Equity
(ttm)
287.23%
Return on Invested Capital
(ttm)
17.46%
Return on Assets
(ttm)
16.16%
Income Statement
Revenue
(ttm)
26.33B
Revenue Per Share
(ttm)
49.35
Gross Profit
(ttm)
19.95B
EBITDA
(ttm)
3
13.00B
Net Income Avi to Common
(ttm)
6.83B
Diluted EPS
(ttm)
12.47
Share Statistics
Beta (5Y Monthly)
0.67
52-Week Change
13.89%
S&P500 52-Week Change
-10.34%
S&P500 Member
Yes
Stock Optionable
Yes
Total Shares Outstanding
1
533.58M
Dividend Yield
3.06%
Float
4
531.13M
%
Held by Insiders
0.46%
%
Held by Institutions
75.53%
Balance Sheet
Total Cash
(mrq)
11.48B
Total Cash Per Share
(mrq)
21.51
Total Debt
(mrq)
38.70B
Total Debt/Equity
(mrq)
1059.51%
Current Ratio
(mrq)
1.68%
Quick Ratio
(mrq)
1.35%
Book Value Per Share
(mrq)
6.85
Cash Flow
Operating Cash Flow Per Share
(ytd)
13.14
Free Cash Flow
(ytd)
6.48B
Table Key
mrq
=
Most Recent Quarter
ttm
=
Trailing Twelve Months
ytd
=
Year To Date
Footnotes
Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.
1
Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2
Market Cap is calculated using total shares outstanding and the most recent share price.
3
EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4
The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Sponsored
Sponsored
This Section / Page contains links to the 3rd party websites of our top partners from whom we may receive compensation.
Trade With A Regulated Broker